Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...
Benchmark analyst Mark Miller raised the firm’s price target on Nova (NVMI) to $295 from $245 and keeps a Buy rating on the shares, stating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback